Similar articles

Abstract: hesperetin, an abundant bioactive component of citrus fruits, is poorly water-soluble, resulting in low oral bioavailability. We developed new formulations to improve the water solubility, antioxidant activity, and oral absorption of hesperetin. Two nano-based formulations were developed, namely hesperetin-TPGS (D-α;-tocopheryl polyethylene glycol 1000 succinate) micelles and hesperetin-phosphatidylcholine (PC) complexes. These two formulations were prepared by a simple technique called solvent dispersion, using US Food and Drug Administration (FDA)-approved excipients for drugs. Differential scanning calorimetry (DSC) and dynamic light scattering (DLS) were used to characterize the formulations’ physical properties. Cytotoxicity analysis, cellular antioxidant activity assay, and a pharmacokinetic study were performed to evaluate the biological properties of these two formulations. The final weight ratios of both hesperetin to TPGS and hesperetin to PC were 1:12 based on their water solubility, which increased to 21.5- and 20.7-fold, respectively. The hesperetin-TPGS micelles had a small particle size of 26.19 nm, whereas the hesperetin-PC complexes exhibited a larger particle size of 219.15 nm. In addition, the cellular antioxidant activity assay indicated that both hesperetin-TPGS micelles and hesperetin-PC complexes increased the antioxidant activity of hesperetin to 4.2- and 3.9-fold, respectively. Importantly, the in vivo oral absorption study on rats indicated that the micelles and complexes significantly increased the peak plasma concentration (C_max) from 2.64 μg/mL to 20.67 and 33.09 μg/mL and also increased the area under the concentration–time curve of hesperetin after oral administration to 16.2- and 18.0-fold, respectively. The micelles and complexes increased the solubility and remarkably improved the in vitro antioxidant activity and in vivo oral absorption of hesperetin, indicating these formulations’ potential applications in drugs and healthcare products.

高水溶性、抗氧化活性和口服吸收率的橙皮素纳米制剂的制备

[1]Attili-Qadri S, Karra N, Nemirovski A, et al., 2013. Oral delivery system prolongs blood circulation of docetaxel nanocapsules via lymphatic absorption. Proc Natl Acad Sci USA, 110(43):17498-17503.

[2]Brand W, van der Wel PAI, Rein MJ, et al., 2008. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos, 36(9):1794-1802.

[3]Choudhury H, Gorain B, Pandey M, et al., 2017. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm, 529(1-2):506-522.

[4]de Souza VT, de Franco ÉPD, de Araújo MEMB, et al., 2016. Characterization of the antioxidant activity of aglycone and glycosylated derivatives of hesperetin: an in vitro and in vivo study. J Mol Recognit, 29(2):80-87.

[5]Dintaman JM, Silverman JA, 1999. Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res, 16(10):1550-1556.

[6]Kanaze FI, Bounartzi MI, Georgarakis M, et al., 2007. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr, 61(4):472-477.

[7]Khan J, Alexander A, Ajazuddin, et al., 2013. Recent advances and future prospects of phyto-phospholipid complexation technique for improving pharmacokinetic profile of plant actives. J Control Release, 168(1):50-60.

[8]Kim HJ, Jeon SM, Lee MK, et al., 2010. Comparison of hesperetin and its metabolites for cholesterol-lowering and antioxidative efficacy in hypercholesterolemic hamsters. J Med Food, 13(4):808-814.

[9]Krasavage WJ, Terhaar CJ, 1977. d-α-Tocopheryl poly(ethylene glycol) 1000 succinate. Acute toxicity, subchronic feeding, reproduction, and teratologic studies in the rat. J Agric Food Chem, 25(2):273-278.

[10]Li Y, Yang DJ, Chen SL, et al., 2008. Process parameters and morphology in puerarin, phospholipids and their complex microparticles generation by supercritical antisolvent precipitation. Int J Pharm, 359(1-2):35-45.

[11]Liu LX, Chen J, 2008. Solubility of hesperetin in various solvents from (288.2 to 323.2) K. J Chem Eng Data, 53(7):1649-1650.

[12]Maiti K, Mukherjee K, Murugan V, et al., 2009. Exploring the effect of hesperetin-HSPC complex—a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics. AAPS PharmSciTech, 10(3):943-950.

[13]Németh K, Plumb GW, Berrin JG, et al., 2003. Deglycosylation by small intestinal epithelial cell β-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr, 42(1):29-42.

[14]Parhiz H, Roohbakhsh A, Soltani F, et al., 2015. Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models. Phytother Res, 29(3):323-331.

[15]Qin LH, Niu YW, Wang YM, et al., 2018. Combination of phospholipid complex and submicron emulsion techniques for improving oral bioavailability and therapeutic efficacy of water-insoluble drug. Mol Pharm, 15(3):1238-1247.

[16]Roohbakhsh A, Parhiz H, Soltani F, et al., 2014. Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin—a mini-review. Life Sci, 113(1-2):1-6.

[17]Shete G, Pawar YB, Thanki K, et al., 2015. Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology. Mol Pharm, 12(4):1158-1170.

[18]Shin GH, Li JL, Cho JH, et al., 2016. Enhancement of curcumin solubility by phase change from crystalline to amorphous in cur-TPGS nanosuspension. J Food Sci, 81(2):N494-N501.

[19]Singh H, Narang JK, Singla YP, et al., 2017. TPGS stabilized sublingual films of frovatriptan for the management of menstrual migraine: formulation, design and antioxidant activity. J Drug Deliv Sci Technol, 41:144-156.

[20]Testai L, Calderone V, 2017. Nutraceutical value of citrus flavanones and their implications in cardiovascular disease. Nutrients, 9(5):502.

[21]Varma MVS, Panchagnula R, 2005. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci, 25(4-5):445-453.

[22]Wang JN, Wang LL, Zhang L, et al., 2018. Studies on the curcumin phospholipid complex solidified with Soluplus^®. J Pharm Pharmacol, 70(2):242-249.

[23]Wolfe KL, Liu RH, 2007. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agric Food Chem, 55(22):8896-8907.

[24]Zhang ZP, Tan SW, Feng SS, 2012. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials, 33(19):4889-4906.

[25]Zhao BX, Gu SF, Du Y, et al., 2018. Solid lipid nanoparticles as carriers for oral delivery of hydroxysafflor yellow A. Int J Pharm, 535(1-2):164-171.